Author:
Wigley Fredrick M.,Reifsnyder Thomas
Publisher
Springer International Publishing
Reference25 articles.
1. Daniels J, Pauling JD, Eccleston C. Behaviour change interventions for the management of Raynaud's phenomenon: a systematic literature review. BMJ Open. 2018;8(12):e024528.
2. Matucci-Cerinic M, Kahaleh B, Wigley FM. Evidence that systemic sclerosis is a vascular disease. Arthritis Rheumatol. 2013;65:1953–62.
3. Wigley FM, Wise RA, Miller R, et al. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum. 1992;35:688–93.
4. Denton CP, Krieg T, Guillevin L, DUO Registry Investigators, et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Ann Rheum Dis. 2012;71:718–21.
5. Rirash F, Tingey PC, Harding SE, et al. Calcium channel blockers for primary and secondary Raynaud’s phenomenon. Cochrane Database Syst Rev. 2017;12:CD000467.